RenovoRx RNXT
NASDAQ RNXT
$1.78 -0.21 (-10.67%)
As of: Sep 10, 2026 · 2:12 PM EDT

RenovoRx (RNXT) Interest Expenses (2020 - 2021)

RenovoRx's (RNXT) quarterly Interest Expenses came in at $208000.0 in Q3 2021, up 11.83% year-over-year from $186000.0 in Q3 2020, and up 11.83% quarter-over-quarter from $186000.0 in Q3 2020.

Analysis

RenovoRx (RNXT) Interest Expenses (2020 - 2021) Analysis & Trends

RenovoRx has disclosed Interest Expenses across 2 years of filings, most recently posting $208000.0 for Q3 2021.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Abbott Laboratories 180.69 Bn 175.09 Bn 7.27 Bn 351.00 Mn
2 Intuitive Surgical 127.23 Bn 122.02 Bn 1.96 Bn -
3 Medtronic 116.90 Bn 108.08 Bn 6.34 Bn 186.00 Mn
4 Stryker 103.91 Bn 100.43 Bn 4.50 Bn 141.00 Mn
5 Boston Scientific 63.54 Bn 63.00 Bn 3.85 Bn 96.00 Mn
6 Edwards Lifesciences 49.74 Bn 45.49 Bn 1.35 Bn -
7 Alcon 32.96 Bn 31.51 Bn 1.68 Bn -53.00 Mn
8 Dexcom 32.02 Bn 30.07 Bn 830.00 Mn -
9 Steris 20.70 Bn 20.21 Bn 684.20 Mn 15.80 Mn
10 RenovoRx 84.43 Mn 84.43 Mn 766,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 208,000.00
Sep 30, 2020 186,000.00